HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

4',7-dihydroxy-3,4-dihydroisoflavone

RN given refers to (S)-isomer; metabolite of daidzein in urine of animals

Also Known As:

4',7-dihydroxyisoflavane; 7,4'-dihydroxyisoflavan; 7-hydroxy-3-(4'-hydroxyphenyl)chroman; NV-07alpha

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        Isoflavones: 2663
        Equol: 297
        4',7-dihydroxy-3,4-dihydroisoflavone: 1

Experts

1.	Barnetson, Ross StC: 1 article (11/2004)
2.	Damian, Diona L: 1 article (11/2004)
3.	Friedmann, Adam C: 1 article (11/2004)
4.	Halliday, Gary M: 1 article (11/2004)
5.	Patterson, Clare R S: 1 article (11/2004)
6.	Reeve, Vivienne E: 1 article (11/2004)
7.	Walker, Catherine: 1 article (11/2004)

Related Diseases

1.

11/01/2004 - "We conclude that 4 mM NV-07alpha prevented the suppressive effects of UV radiation on Mantoux responses in humans but did not affect UV-induced erythema at the concentrations used."
11/01/2004 - "NV-07alpha had no significant effects on UV erythema. "
11/01/2004 - "Minimal erythema doses were also determined for sites treated with NV-07alpha or its vehicle immediately after UV exposure. "
11/01/2004 - "Although lower concentrations of NV-07alpha (0.5 and 2 mM) did not prevent UV immunosuppression, 4 mM NV-07alpha partially but significantly attenuated UV-induced suppression of Mantoux-induced erythema. "